CAS and Kalexsyn agree to a multi-year contract to offer unlimited SciFinder® access to researchers
Chemical Abstracts Service (CAS), the world’s authority for chemical information, announced today a three-year agreement for SciFinder®, the choice for chemistry research, with Kalexsyn, a Contract Research Organization (CRO) uniquely positioned to address the needs of the pharmaceutical and biotechnology communities.
Scientist-turned-entrepreneur Bob Gadwood of Kalexsyn is the next speaker in the WMU Entrepreneurship Forum series
Entrepreneurship was probably not the top thing on the minds of Kalamazoo-based scientists after Pfizer Inc. completed its buy-out of Pharmacia Corp. in 2003 and started to eliminate a lot of the research work done here.
But Bob Gadwood was among several Pharmacia/Pfizer scientists who enjoyed the work they did here, enjoyed living here and decided to take their skill sets and become entrepreneurs.